title: [A case of emphysematous pyelonephritis improved with conservative therapy--indication for conservative therapy].
abstract: A 51-year-old female patient was hospitalized in our department with high fever and left flank pain. Laboratory examination showed leukocytosis, increase of C-reactive protein (CRP), hyperglycemia and renal insufficiency. Enterobacter aerogenes grew out of the cultured urine. The radiograph and computerized tomographic (CT) scan revealed streaky gas in the destroyed left renal parenchyma with perirenal gas. She was diagnosed with left emphysematous pyelonephritis. Antibiotics therapy, treatment for sepsis and disseminated intravesicular coagulation was initiated resulting in mitigation of inflammation. High blood glucose initially required insulin therapy, but finally returned to normal levels through administration of oral antidiabetics. Although leukocytosis and low grade fever continued, the patient was discharged on day 53 with a negative CRP. CT scan indicated that the emphysematous change was localized after three months and almost resolved after four months. Renal scintigram indicated the residual function of the affected kidney. Because of the possibility of residual renal function and the cure by conservative therapy alone, the conservative therapy is preferred when the initial treatment is effective.
authors.affiliation: Department of Urology, Saiseikai Kawaguchi General Hospital.
authors.forename: T
authors.initials: T
authors.lastname: Kondo
authors.forename: H
authors.initials: H
authors.lastname: Okuda
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Okumura
authors.forename: H
authors.initials: H
authors.lastname: Toma
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004646:Emphysema / Q000150:complications / Q000188:drug therapy*; D004754:Enterobacter; D004756:Enterobacteriaceae Infections; D005260:Female; D016670:Gabexate / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011704:Pyelonephritis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome; D005719:gamma-Globulins / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D005719:gamma-Globulins; D016670:Gabexate